Indication: VONVENDI [von Willebrand factor (recombinant)] is used in adults (age 18 years and older) diagnosed with von Willebrand disease to: treat and control bleeding episodes and prevent excessive bleeding during and after surgery


Resources and Support

Shire. Extending our legacy in bleeding disorders to VWD

VONVENDI® [von Willebrand factor (Recombinant)] is brought to you by Shire. Shire's hematology business is dedicated to developing and manufacturing treatments for bleeding disorders.

Shire is committed to helping improve the lives of adults living with von Willebrand disease (VWD). Our services are designed with your needs in mind.

Shire's website is filled with helpful information and links to resources ranging from community and educational programs to financial assistance options. Shire support programs are available to all patients, regardless of treatment.

Learn more
See Shire's resources available to adults living with VWD

Vonvendi Free Trial Program

Eligible patients can try VONVENDI with 3 free doses

Learn more

Are you covered?

Find out which insurance plans include VONVENDI

See how


Give us your name; we'll give you information

Sign Up

Locate resources

Identify a hemophilia treatment center
or Shire representative

Go to locator tools
Representative Finder: Find your local Shire representative

Representative finder

A Shire representative can answer your questions about VONVENDI®

Help me out
Insurance support is available from Shire

Starting out

Find out how we can get you started

Learn more